Cipher Pharmaceuticals Inc. (CPH.TO)
| Previous Close | 9.30 |
| Open | 9.36 |
| Bid | 9.19 x 0 |
| Ask | 9.24 x 0 |
| Day's Range | 9.22 - 9.48 |
| 52 Week Range | 3.18 - 9.98 |
| Volume | |
| Avg. Volume | 45,732 |
| Market Cap | 222.751M |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | 8.48 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2024 after the market close on Thursday, May 9, 2024. The Company will also hold a conference call on Friday, May 10, 2024 at 8:30 ET to discuss the results and corporate developments.
- Newsfile
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024Time:8:30 AM-5:00 PM ETLocation: Metro Toronto Convention Centre, North Building 255 Front St W Toronto, Ontario M5V 2W6 CEO Craig Mull ...
- CNW Group
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the year ended December 31, 2023.
